AAPL 250.9362 1.1636% MSFT 439.85 0.5624% NVDA 132.26 2.5987% GOOGL 190.36 1.0403% GOOG 191.585 0.7547% AMZN 224.7026 1.8967% META 605.1 1.3245% AVGO 221.57 -0.9167% TSLA 434.8 -1.211% TSM 195.3 -0.133% LLY 758.87 -0.7637% V 315.9 1.9756% JPM 234.325 1.7168% UNH 493.79 -1.1867% NVO 103.7 -2.1329% WMT 93.89 0.3634% LVMUY 130.52 0.7721% XOM 105.67 -0.7048% LVMHF 649.5 0.6649% MA 526.755 1.3068%

CareMax Inc

Healthcare US CMAX

0.0302USD
-0.0975(76.35%)

Last update at 2024-12-18T14:30:00Z

Day Range

0.020.14
LowHigh

52 Week Range

0.1017.40
LowHigh

Fundamentals

  • Previous Close 0.13
  • Market Cap6.91M
  • Volume925318
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-108.32700M
  • Revenue TTM784.55M
  • Revenue Per Share TTM208.34
  • Gross Profit TTM 80.30M
  • Diluted EPS TTM-208.91

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -57.33900M -6.51700M 7.57M - -
Minority interest - 0.00000M 0.03M -0.21420M -0.15135M
Net income -37.79700M -6.67600M 5.94M - -
Selling general administrative 75.82M 40.58M 7.75M - -
Selling and marketing expenses 11.76M 4.96M 1.07M - -
Gross profit 80.30M 31.45M 20.00M - -
Reconciled depreciation 21.72M 13.21M 1.50M - -
Ebit -29.00200M -27.30100M 9.68M 6.57M 3.49M
Ebitda -6.73700M -34.90000M 11.18M - -
Depreciation and amortization 22.27M -7.59900M 1.50M - -
Non operating income net other - 21.00M - - -
Operating income -29.00200M -27.30100M 9.68M - -
Other operating expenses 660.13M 323.06M 93.74M - -
Interest expense 20.24M 4.49M 1.66M 0.00000M 0.00000M
Tax provision -19.54200M 0.16M 0.00000M - -
Interest income - - 17.50M - -
Net interest income -20.24200M -4.49200M -1.65900M - -
Extraordinary items - - - - -
Non recurring - 1.52M - - -
Other items - - - - -
Income tax expense -19.54200M 0.16M 1.63M - -
Total revenue 631.13M 295.76M 103.42M - -
Total operating expenses 109.30M 58.75M 10.32M - -
Cost of revenue 550.83M 264.31M 83.42M - -
Total other income expense net -28.33700M 20.78M -2.11000M - -
Discontinued operations - - - - -
Net income from continuing ops -37.79600M -6.67500M 7.57M - -
Net income applicable to common shares -37.79600M -6.67500M 7.60M 6.02M 3.47M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 623.30M 1170.74M 653.09M 38.50M -
Intangible assets 101.24M 123.58M 59.81M 8.57M -
Earning assets - - - - -
Other current assets 3.07M 3.95M 0.54M 0.08M 0.13M
Total liab 561.86M 551.20M 147.72M 31.78M -
Total stockholder equity 61.44M 619.55M 505.37M 6.73M -
Deferred long term liab - 1.69M 1.97M - -
Other current liab 59.18M 33.59M 3.88M 0.64M 0.46M
Common stock 0.01M 0.01M 0.00900M 0.22M 0.22M
Capital stock 0.01M 0.01M 0.00900M 0.22M -
Retained earnings -720.93800M -37.59000M 0.03M -3.92509M -
Other liab - 146.61M 14.80M - -
Good will 156.84M 700.64M 464.57M 10.07M -
Other assets - 0.00100M 4.68M 0.18M 0.19M
Cash 65.53M 41.63M 47.92M 4.93M -
Cash and equivalents - - - - -
Total current liabilities 438.81M 77.32M 21.96M 5.45M 3.34M
Current deferred revenue - - 8.69M 2.76M -
Net debt 426.41M 321.68M 69.32M 22.39M -
Short term debt 373.36M 36.04M 6.28M 1.00M -
Short long term debt 364.57M 30.53M 6.28M 1.00M -
Short long term debt total 491.93M 363.31M 117.23M 27.33M -
Other stockholder equity 782.37M 657.13M 505.33M 6.50M 4.94M
Property plant equipment - 129.94M 15.99M 4.80M 3.45M
Total current assets 183.35M 197.34M 108.04M 14.88M 10.06M
Long term investments - - - - -
Net tangible assets - -204.68100M -19.00700M -11.91631M -5.45979M
Short term investments - - - 143.84M -
Net receivables 114.75M 151.04M 42.00M 9.67M 5.30M
Long term debt 21.44M 230.72M 110.96M 26.32M -
Inventory 0.00000M 0.72M 0.55M 0.01M 0.01M
Accounts payable 6.28M 7.69M 3.11M 1.04M 1.52M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - 0.00900M 131.74M -
Preferred stock total equity - - - - -
Retained earnings total equity - - 0.03M -21.51074M -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 24.74M 19.23M 4.68M 0.18M -
Deferred long term asset charges - - 1.97M - -
Non current assets total 439.95M 973.41M 545.05M 23.62M -
Capital lease obligations 106.11M 102.05M - - -
Long term debt total - - 110.96M - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -62.50200M -316.57900M -6.94200M - -
Change to liabilities 1.73M -0.98400M -0.68592M 0.21M 1.17M
Total cashflows from investing activities -62.50200M -316.57900M -6.61305M -11.22665M -0.93464M
Net borrowings - 97.29M 5.48M 12.80M 0.34M
Total cash from financing activities 124.43M 383.42M 2.12M 8.37M 0.34M
Change to operating activities - 0.15M 0.51M 0.36M -0.64645M
Net income -37.79600M -6.67500M 7.57M 6.02M 3.47M
Change in cash -6.29100M 42.98M 0.50M 4.16M -0.00767M
Begin period cash flow 47.92M 4.93M 4.44M - -
End period cash flow 41.63M 47.92M 4.93M 4.44M -
Total cash from operating activities -68.21600M -23.85600M 5.32M 7.02M 0.58M
Issuance of capital stock 0.00000M 415.00M 0.00000M - -
Depreciation 21.72M 13.21M 1.50M 0.98M 0.60M
Other cashflows from investing activities 0.79M -312.58900M -143.75000M 0.00100M 0.00100M
Dividends paid - 0.00000M 3.69M 4.30M 4.30M
Change to inventory -0.17200M -0.08500M -0.00500M -0.00019M -0.00159M
Change to account receivables -66.56100M -3.83600M -4.20800M -0.46314M -4.02313M
Sale purchase of stock - 402.53M 143.78M - -
Other cashflows from financing activities 246.41M -3.87100M 6.24M -0.12500M -0.12500M
Change to netincome - -26.50900M 0.42M -0.15993M 0.02M
Capital expenditures 7.45M 6.87M 2.15M 0.73M 0.38M
Change receivables - -3.83600M - - -
Cash flows other operating - 7.76M - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - 42.98M - - -
Change in working capital -53.75200M -4.75300M -4.38500M - -
Stock based compensation 10.27M 1.34M 0.00000M - -
Other non cash items 10.88M -4.59700M 0.63M - -
Free cash flow -75.66600M -30.72800M 3.17M - -

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CMAX
CareMax Inc
-0.0975 76.35% 0.03 - - 0.002 0.40 0.63 -0.7432
GEHC
GE HealthCare Technologies Inc.
0.62 0.80% 77.71 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A
-2.02 0.91% 219.52 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc
- -% 9.73 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc
-0.13 2.97% 4.25 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

Profile

CareMax, Inc. provides care and chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, New York, Tennessee, and Texas. The company is headquartered in Miami, Florida. On November 17, 2024, CareMax, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Northern District of Texas.

CareMax Inc

1000 NW 57th Court, Miami, FL, United States, 33126

Key Executives

Name Title Year Born
Mr. Carlos A. de Solo Co-Founder, Pres, CEO & Director 1979
Mr. Kevin C. Wirges Exec. VP, CFO & Treasurer 1980
Mr. Alberto R. de Solo Exec. VP & COO 1977
Mr. Erick Anthony Fernandez Chief Accounting Officer 1979
Samantha Swerdlin VP of Investor Relations NA
Meredith Longsworth Sr. VP, Gen. Counsel & Sec. NA
Teresa McMeans Chief Compliance Officer NA
Regla Wuilchrist Chief People Officer NA
Mr. Niberto Moreno M.D. Chief Medical Officer NA
Nicole Cable Chief Experience Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.